Literature DB >> 10967033

Ocular gene therapy: quo vadis?

W W Hauswirth1, L Beaufrere.   

Abstract

Mesh：

Year:  2000        PMID： 10967033

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN： 0146-0404            Impact factor:   4.799


× No keyword cloud information.
  10 in total

1.  Gene transfer mediated by recombinant baculovirus into mouse eye.

Authors:  F Haeseleer; Y Imanishi; D A Saperstein; K Palczewski
Journal:  Invest Ophthalmol Vis Sci       Date:  2001-12       Impact factor: 4.799

2.  Neural retina limits the nonviral gene transfer to retinal pigment epithelium in an in vitro bovine eye model.

Authors:  Leena Pitkänen; Jukka Pelkonen; Marika Ruponen; Seppo Rönkkö; Arto Urtti
Journal:  AAPS J       Date:  2004-10-07       Impact factor: 4.009

3.  A comprehensive mutation analysis of RP2 and RPGR in a North American cohort of families with X-linked retinitis pigmentosa.

Authors:  Debra K Breuer; Beverly M Yashar; Elena Filippova; Suja Hiriyanna; Robert H Lyons; Alan J Mears; Bersabell Asaye; Ceren Acar; Raf Vervoort; Alan F Wright; Maria A Musarella; Patricia Wheeler; Ian MacDonald; Alessandro Iannaccone; David Birch; Dennis R Hoffman; Gerald A Fishman; John R Heckenlively; Samuel G Jacobson; Paul A Sieving; Anand Swaroop
Journal:  Am J Hum Genet       Date:  2002-04-30       Impact factor: 11.025

4.  Vitreous is a barrier in nonviral gene transfer by cationic lipids and polymers.

Authors:  Leena Pitkänen; Marika Ruponen; Jenni Nieminen; Arto Urtti
Journal:  Pharm Res       Date:  2003-04       Impact factor: 4.200

5.  Gene therapy in glaucoma-3: Therapeutic approaches.

Authors:  Mohamed Abdel-Monem Soliman Mahdy
Journal:  Oman J Ophthalmol       Date:  2010-09

6.  Layer-specific nanophotonic delivery of therapeutic opsin-encoding genes into retina.

Authors:  Subrata Batabyal; Sanghoon Kim; Weldon Wright; Samarendra Mohanty
Journal:  Exp Eye Res       Date:  2021-01-28       Impact factor: 3.770

7.  Ocular localization and transduction by adenoviral vectors are serotype-dependent and can be modified by inclusion of RGD fiber modifications.

Authors:  Kazuhiro Ueyama; Keisuke Mori; Takuhei Shoji; Hidekazu Omata; Peter L Gehlbach; Douglas E Brough; Lisa L Wei; Shin Yoneya
Journal:  PLoS One       Date:  2014-09-18       Impact factor: 3.240

Review 8.  Progress in Gene Therapy to Prevent Retinal Ganglion Cell Loss in Glaucoma and Leber's Hereditary Optic Neuropathy.

Authors:  Sara E Ratican; Andrew Osborne; Keith R Martin
Journal:  Neural Plast       Date:  2018-05-02       Impact factor: 3.599

9.  An empty E1, E3, E4 adenovirus vector protects photoreceptors from light-induced degeneration.

Authors:  Hiroyasu Takita; Shin Yoneya; Peter L Gehlbach; Lisa L Wei; Keisuke Mori
Journal:  J Ocul Biol Dis Infor       Date:  2008-05-22

10.  Genetic and functional dissection of ARMS2 in age-related macular degeneration and polypoidal choroidal vasculopathy.

Authors:  Yong Cheng; LvZhen Huang; Xiaoxin Li; Peng Zhou; Wotan Zeng; ChunFang Zhang
Journal:  PLoS One       Date:  2013-01-09       Impact factor: 3.240
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.